Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

All 48Congress 0Executive branch 0Insiders 48
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TVTX · 48 trades

Trades
48
Buys 0 · Sells 48
People
11
Stocks
1
Disclosed value
$67.7M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$1.8Mdisclosed Sep 17 · filed 2 days after the trade
  2. ▼ SELLEric M Dube Chief Executive OfficerTVTX Travere Therapeutics, Inc.$6.6Mdisclosed Sep 17 · filed the same day
  3. ▼ SELLSandra Calvin SVP, Chief Accounting OfficerTVTX Travere Therapeutics, Inc.$266Kdisclosed Sep 17 · filed 2 days after the trade
  4. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$3Mdisclosed Sep 17 · filed 1 day after the trade
  5. ▼ SELLPeter Heerma EVP, Chief Commercial OfficerTVTX Travere Therapeutics, Inc.$93.5Kdisclosed Sep 17 · filed 2 days after the trade
  6. ▼ SELLChristopher R. Cline Chief Financial OfficerTVTX Travere Therapeutics, Inc.$121Kdisclosed Sep 17 · filed 2 days after the trade
  7. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$191Kdisclosed Sep 17 · filed 2 days after the trade
  8. ▼ SELLWilliam E. Rote Chief Research OfficerTVTX Travere Therapeutics, Inc.$17.6Kdisclosed Sep 17 · filed 2 days after the trade
  9. ▼ SELLChristopher R. Cline Chief Financial OfficerTVTX Travere Therapeutics, Inc.$26.1Kdisclosed Sep 17 · filed 2 days after the trade
  10. ▼ SELLJula Inrig EVP, Head of R&D & CMOTVTX Travere Therapeutics, Inc.$1.6Mdisclosed Sep 17 · filed 2 days after the trade
  11. ▼ SELLElizabeth E Reed Chief Legal Officer and GCTVTX Travere Therapeutics, Inc.$89.2Kdisclosed Sep 17 · filed 2 days after the trade
  12. ▼ SELLJeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.$211Kdisclosed Sep 11 · filed 1 day after the trade
  13. ▼ SELLJeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.$111Kdisclosed Sep 11 · filed 1 day after the trade
  14. ▼ SELLJeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.$944Kdisclosed Sep 11 · filed 1 day after the trade
  15. ▼ SELLJeffrey A Meckler DirectorTVTX Travere Therapeutics, Inc.$79.4Kdisclosed Sep 11 · filed 1 day after the trade
  16. ▼ SELLChristopher R. Cline Chief Financial OfficerTVTX Travere Therapeutics, Inc.$42.6Kdisclosed Sep 3 · filed 1 day after the trade
  17. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$57.5Kdisclosed Aug 19 · filed 1 day after the trade
  18. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$32.1Kdisclosed Aug 19 · filed 2 days after the trade
  19. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$165Kdisclosed Aug 19 · filed 2 days after the trade
  20. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$119Kdisclosed Aug 19 · filed 2 days after the trade
  21. ▼ SELLGary A Lyons DirectorTVTX Travere Therapeutics, Inc.$259Kdisclosed Aug 19 · filed 1 day after the trade
  22. ▼ SELLRoy D. Baynes DirectorTVTX Travere Therapeutics, Inc.$225Kdisclosed Jun 16 · filed 4 days after the trade
  23. ▼ SELLTimothy Coughlin DirectorTVTX Travere Therapeutics, Inc.$501Kdisclosed Jun 16 · filed 4 days after the trade